Infectious Diseases – News and Features

Biosearch now licenses the BHQ technology to major custom oligo providers in the U.S. and Europe.

Centers for Disease Control and Prevention unveils a series of papers which analyze the most detailed and comprehensive clinical study on CFS to date.

Xenomics scientists contribute chapter on potential of Transrenal-DNA diagnostic technology.

Benitec has reduced its workforce by 50%, anticipating a nearly US$100,000 monthly savings.

The results pave the way for the testing of a recombinant sLAG-3 protein as an adjuvant therapy for breast cancer in clinical trials.

The patented Mitox™ technology covers the measurement of mitochondrial DNA and RNA as a biomarker in the assessment of efficacy and unwanted adverse events of treatment.

The study covers detection of DNA variation or RNA expression with the intent to diagnose disease, determine a patient’s susceptibility to disease, or determine the prognosis of condition.

Alnylam will collaborate with USAMRIID to discover RNAi therapeutics targeting viral organisms.

The two year programme will optimise the effectiveness of nanomaterials and assess their toxicology for different antiviral applications

Nanospray mass spectrometry was used to demonstrate the feasibility of detecting norovirus particles in the purified concentrates.